Clostridium difficile and Clostridium perfringens research
Clostridium difficile and Clostridium perfringens research is a research topic within Infectious Diseases. Science Explorer counts 30k research works in it since 1950. 23.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the epidemiology, treatment, and prevention of Clostridium difficile infection, with a particular emphasis on fecal microbiota transplantation, antibiotic-associated diarrhea, healthcare-associated infections, toxin production, and clinical practice guidelines. It also explores the role of microbiome diversity, vancomycin and metronidazole treatment, risk factors for infection, and bacterial toxins associated with the disease.
- Fecal Microbiota Transplantation
- Antibiotic-Associated Diarrhea
- Healthcare-Associated Infections
- Toxin Production
- Epidemiology
- Clinical Practice Guidelines
- Microbiome Diversity
- Vancomycin and Metronidazole Treatment
- Risk Factors
- Bacterial Toxins
- Research works
- 30k fractional, since 1950
- In the world top 10%
- 7k per year above
- Top-10% rate
- 23.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +40% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Clostridium difficile and Clostridium perfringens research research?
By volume, the United States and China publish the most (1.5k and 1.3k works in 2022–2025).
By volume, 2022–2025
- 1 United States 1.5k works
- 2 China 1.3k works
- 3 India 244 works
- 4 United Kingdom 208 works
- 5 Germany 201 works
- 6 Japan 199 works
- 7 France 194 works
- 8 Italy 174 works
- 9 Canada 159 works
- 10 Spain 146 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Clostridium difficile and Clostridium perfringens research research?
By volume in 2022–2025, University of North Carolina at Chapel Hill publishes the most Clostridium difficile and Clostridium perfringens research research, followed by Chinese University of Hong Kong and University of Michigan.
By volume, 2022–2025
- 1 University of North Carolina at Chapel Hill United States 21 works
- 2 Chinese University of Hong Kong Hong Kong 19 works
- 3 University of Michigan United States 18 works
- 4 Zhejiang University China 17 works
- 5 Shanghai Jiao Tong University China 17 works
- 6 Sichuan University China 16 works
- 7 Chinese Academy of Medical Sciences & Peking Union Medical College China 16 works
- 8 University of California, Davis United States 15 works
- 9 China Agricultural University China 15 works
- 10 Harvard University United States 15 works
Where is Clostridium difficile and Clostridium perfringens research research done?
The largest centres of Clostridium difficile and Clostridium perfringens research research in 2022–2025 are Beijing (China), Guangzhou (China), Shanghai (China) and Paris (France).
Where is the best place to study Clostridium difficile and Clostridium perfringens research?
Among universities, judged by research, Chinese University of Hong Kong, Chinese Academy of Medical Sciences & Peking Union Medical College and China Agricultural University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese University of Hong Kong Hong Kong | 82.9 | 46.0% | 4.4× | 19 | +322.9% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical College China | 63.1 | 42.6% | 2.7× | 16 | +315.5% |
| 3 | China Agricultural University China | 61.1 | 34.3% | 4.5× | 16 | +364.4% |
| 4 | Shanghai Jiao Tong University China | 56.5 | 37.2% | 1.3× | 17 | +245.0% |
| 5 | Harvard University United States | 54.7 | 40.7% | 2.0× | 15 | +53.1% |
| 6 | Washington University in St. Louis United States | 53.6 | 44.0% | 3.3× | 14 | +20.0% |
| 7 | University of Houston United States | 50.9 | 19.1% | 6.4× | 13 | +345.7% |
| 8 | Nanjing Medical University China | 49.4 | 32.4% | 4.4× | 13 | +115.3% |
| 9 | Yangzhou University China | 49.4 | 38.3% | 3.2× | 11 | +133.7% |
| 10 | Sun Yat-sen University China | 48.3 | 35.1% | 1.3× | 12 | +335.0% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Clostridium difficile and Clostridium perfringens research research growing?
Output in 2018–2022 was 40% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Clostridium difficile and Clostridium perfringens research.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.